AlphAIAlphAI — Financial news for AI agents
yahoo.comSEP 33 min read$MDT

4 Reasons to Buy Medtronic Stock Like There's No Tomorrow

Medtronic (MDT) reported 8.4% revenue growth in fiscal 2026, driven by cardiovascular business. It expects 7.25%-7.75% organic growth in fiscal 2027. Free cash flow rose 4.6% to $5.43B. The company offers a 3.1% yield and has raised dividends for 49 years. Analysts project 14% EPS growth from 2026-2029, with the stock trading at 18x forward earnings.

Original reporting
yahoo.com
Published Sep 3, 2026, 5:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 5:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
4 Reasons to Buy Medtronic Stock Like There's No Tomorrow — source image
Source · yahoo.com
Decision brief

The 30-second read

$MDTBullishMed
01

Why it matters

The disclosed earnings beat and guidance could trigger buying pressure, especially from dividend‑focused funds.

02

Market read

First report of FY2026 results provides fresh material for traders; upside potential if market re‑prices growth narrative.

03

What to watch

Potential regulatory or reimbursement risks could temper upside.

Relevance 7/10Novelty 8/10Timing: post‑earnings release

Background

Medtronic has addressed supply‑chain and cost issues, spun off its diabetes unit, and is targeting dividend‑king status.

Company-level read

Ticker impact

$MDTBullishHigh confidence
Context

Fiscal 2026 revenue grew 8.4% to $36.4B and free cash flow rose 4.6% to $5.43B, indicating a turnaround.

Expected impact

Potential upside as investors re‑rate growth prospects.

Evidence & confidence

First‑time disclosure of strong FY2026 results and guidance suggests a material catalyst.

Market effects

Sector

Medical‑device sector may see renewed interest as a leading player shows growth.

Regional

U.S. healthcare stocks could benefit from MDT's upside.

Global

Limited to investors focused on U.S. med‑tech equities.

Counterpoint

What could challenge this read

Valuation still high relative to peers; growth may not sustain.

Key entities

  • Company
    Medtronic

    Global medical‑device manufacturer (NYSE: MDT).

Read at source← All news

Related articles

OCT 9
$MDTMed

Medtronic (MDT) Commits $700 Million To Robotics As 2026 Impact Report Lands

Medtronic (MDT) announced a $700 million investment in its surgical robotics platform, part of a broader shift toward digital health and AI-driven care. The company released its 2026 Impact Report, outlining progress in AI tools, workforce goals, and environmental targets. Management aims to transform Medtronic into a multi-platform medtech group, focusing on robotics, data-driven care, and digital health.

finance.yahoo.com2 min
OCT 8
$MDTMed

Medtronic sets MiniMed exchange ratio at 4.5939

Medtronic plc has set the exchange ratio for its offer to swap up to 225,361,295 shares of MiniMed Group, Inc. common stock for its own shares at 4.5939 MiniMed shares per Medtronic share. The exchange is subject to proration if oversubscribed, with Medtronic potentially accepting up to 55,032,401 of its shares. The final ratio was announced on October 7, 2026.

stocktitan.net4 min
OCT 7
$MDTHighAI 8/10

Medtronic Sets MiniMed Split-Off Exchange Ratio at 4.5939 Upper Limit

Medtronic (MDT) set the final exchange ratio for its split-off of MiniMed (MMED) at 4.5939 shares of MMED for each MDT share. The ratio is at the offer's upper limit, valuing MDT shares at 100% and MMED at 93% of their average prices. The offer expires October 9, 2026, and may be oversubscribed, with proration possible. The exchange is expected to be tax-free for U.S. federal income tax purposes.

securities.io2 min
OCT 7
$MDTHighAI 8/10

Medtronic sets final exchange ratio for MiniMed split-off

Medtronic (NYSE:MDT) set the final exchange ratio for its offer to swap shares for MiniMed (NASDAQ:MMED) stock at 4.5939. The company will exchange up to 225,361,295 MiniMed shares. If oversubscribed, Medtronic may exchange additional shares without extending the offer. The exchange offer expires at midnight on Friday.

investing.com2 min